Premium
Profunda artery perforator flap for isolated vulvar defect reconstruction after oncological resection
Author(s) -
Chang Tommy NaiJen,
Lee CheHsiung,
Lai ChyongHuey,
Wu ChihWei,
Chang ChunShin,
Cheng MingHuei,
Huang JungJu
Publication year - 2016
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.24233
Subject(s) - medicine , surgery , perforator flaps , thoracodorsal artery , vulvar cancer , debridement (dental) , free flap , vulva
Summary Isolated vulvar reconstruction using profunda artery‐based perforator flaps have good functional as well as quality of life restoration. Surgical techniques, complications, and final evaluation using questionnaires are presented. Background Vulvar reconstruction remains a great challenge to reconstructive surgeons. A local fasciocutaneous flap from the medial thigh is a good option with multiple choices of the donor arteries. Here, we extended the clinical application of a profunda perforator artery (PAP) flap with the design of an island pedicle flap. Methods From 2012 to 2015, 12 female patients with vulvar cancer received tumor ablation and immediate reconstruction using a PAP flap. The flaps (n = 19) were divided into V‐Y advancement perforator flap (group I, n = 4) and island pedicle perforator flap (group II, n = 15). All of the demographic data were collected and analyzed. Results All of the flaps were transferred successfully, and all of the donor sites were closed without morbidities. Group II was superior to group I because of the smaller required flap size ( P = 0.004), the smaller defect size/flap size ratio ( P = 0.001), and a lower rate of post‐op debridement ( P = 0.037). The other parameters were not statistically significant. Conclusions PAP flap is a good choice for vulvar reconstruction. We preferred an island pedicle setting for its thin and pliable fasciocutaneous component and robust flap circulation. The favorable functional and aesthetic results can be achieved with limited donor site morbidities. J. Surg. Oncol. 2016;113:828–834 . © 2016 Wiley Periodicals, Inc.